Transcriptome Modifications in Porcine Adipocytes Via Toll-Like Receptors Activation
Overview
Authors
Affiliations
Adipocytes are the most important cell type in adipose tissue playing key roles in immunometabolism. We previously reported that nine members of the Toll-like receptor (TLR) family are expressed in an originally established porcine intramuscular pre-adipocyte (PPI) cell line. However, the ability of TLR ligands to modulate immunometabolic transcriptome modifications in porcine adipocytes has not been elucidated. Herein, we characterized the global transcriptome modifications in porcine intramuscular mature adipocytes (pMA), differentiated from PPI, following stimulation with Pam3csk4, Poly(I:C) or LPS which are ligands for TLR2, TLR3, and TLR4, respectively. Analysis of microarray data identified 530 (218 up, 312 down), 520 (245 up, 275 down), and 525 (239 up, 286 down) differentially expressed genes (DEGs) in pMA following the stimulation with Pam3csk4, Poly(I:C), and LPS, respectively. Gene ontology classification revealed that DEGs are involved in several biological processes including those belonging to immune response and lipid metabolism pathways. Functionally annotated genes were organized into two groups for downstream analysis: immune response related genes (cytokines, chemokines, complement factors, adhesion molecules, and signal transduction), and genes involved with metabolic and endocrine functions (hormones and receptors, growth factors, and lipid biosynthesis). Differential expression analysis revealed that , and are the top 10 commonly altered genes of TLRs induced transcriptional modification of pMA. However, the protein-protein interaction network of DEGs identified , and as the major hub genes, which were also exhibited higher centrality estimates in the Gene-Transcription factor interaction network. Our results provide new insights of transcriptome modifications associated with TLRs activation in porcine adipocytes and identified key regulatory genes that could be used as biomarkers for the evaluation of treatments having immunomodularoty and/or metabolic functional beneficial effects in porcine adipocytes.
Chen T, Xu T, Wang J, Zhang T, Yang J, Feng L BMC Plant Biol. 2024; 24(1):595.
PMID: 38914931 PMC: 11197285. DOI: 10.1186/s12870-024-05306-y.
Chen W, Xiao Y, Yang F, Liufu S, Gong Y, Li Z Front Genet. 2024; 15:1393834.
PMID: 38808333 PMC: 11130441. DOI: 10.3389/fgene.2024.1393834.
Kober A, Saha S, Ayyash M, Namai F, Nishiyama K, Yoda K Nutrients. 2024; 16(9).
PMID: 38732619 PMC: 11085650. DOI: 10.3390/nu16091373.
Transcriptome Analysis Reveals the Multiple Functions of pBD2 in IPEC-J2 Cells against .
Lian S, Lin X, Zhan F, Shen X, Liang Y, Li C Int J Mol Sci. 2022; 23(17).
PMID: 36077151 PMC: 9456188. DOI: 10.3390/ijms23179754.
Herrera-Uribe J, Liu H, Byrne K, Bond Z, Loving C, Tuggle C Front Genet. 2020; 11:817.
PMID: 32973863 PMC: 7468443. DOI: 10.3389/fgene.2020.00817.